Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Stem Cells

Volumn 35, Issue 10, 2017, Pages 2138-2149

  Lee, Won Hee ^a   Chen, Wen Yi ^a   Shao, Ning Yi ^a   Xiao, Dan ^a   Qin, Xulei ^a   Baker, Natalie ^a   Bae, Hye Ryeong ^a   Wei, Tzu Tang ^a   Wang, Yongjun ^a   Shukla, Praveen ^a   Wu, Haodi ^a   Kodo, Kazuki ^a   Ong, Sang Ging ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell therapy; Embryonic stem cell derived cardiomyocyte; Exosomes; Induced pluripotent stem cell derived cardiomyocyte; Stem cells

Indexed keywords

CD31 ANTIGEN; FIBROBLAST SURFACE PROTEIN 1; KRUPPEL LIKE FACTOR 4; LONG UNTRANSLATED RNA; MICRORNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; TRANSCRIPTION FACTOR SOX2; TROPONIN T; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ADULT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CELL LEVEL; CELL TRANSPLANTATION; ELECTROPHYSIOLOGY; ENDOTHELIUM CELL; EXOSOME; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HEART FUNCTION; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; HYPOXIA; IMMUNOFLUORESCENCE; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; NONHUMAN; RAT; SMOOTH MUSCLE CELL; CELL CULTURE; METABOLISM;

CELL DIFFERENTIATION; CELLS, CULTURED; EXOSOMES; HUMAN EMBRYONIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC;

EID: 85026475074     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2669     Document Type: Article

References (26)

1. Matsa E, Sallam K, Wu JC. Cardiac stem cell biology: Glimpse of the past, present, and future. Circ Res 2014;114:21–27.
2. Laflamme MA, Chen KY, Naumova AV et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015–1024.
3. Fernandes S, Naumova AV, Zhu WZ et al. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol 2010;49:941–949.
4. Shiba Y, Fernandes S, Zhu WZ et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012;489:322–325.
5. Chong JJ, Yang X, Don CW et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014;510:273–277.
6. Menasche P, Vanneaux V, Hagege A et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: First clinical case report. Eur Heart J 2015;36:2011–2017.
7. Neofytou E, O'Brien CG, Couture LA, et al. Hurdles to clinical translation of human induced pluripotent stem cells. J Clin Invest 2015;125:2551–2557.
8. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–676.
9. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917–1920.
10. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318–324.
11. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111–123.
12. Narsinh KH, Plews J, Wu JC. Comparison of human induced pluripotent and embryonic stem cells: Fraternal or identical twins? Mol Ther 2011;19:635–638.
13. Yellon DM, Davidson SM. Exosomes: Nanoparticles involved in cardioprotection? Circ Res 2014;114:325–332.
14. Burridge PW, Matsa E, Shukla P et al. Chemically defined generation of human cardiomyocytes. Nat Methods 2014;11:855–860.
15. Ong SG, Huber BC, Lee WH et al. Microfluidic single-cell analysis of transplanted human induced pluripotent stem cell-derived cardiomyocytes after acute myocardial infarction. Circulation 2015;132:762–771.
16. Ong SG, Lee WH, Huang M et al. Cross talk of combined gene and cell therapy in ischemic heart disease: Role of exosomal microRNA transfer. Circulation 2014;130:S60–S69.
17. He B, Xiao J, Ren AJ et al. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci 2011;18:22.
18. Gu GL, Xu XL, Sun XT et al. Cardioprotective effect of microRNA-21 in murine myocardial infarction. Cardiovasc Ther 2015;33:109–117.
19. Roca-Alonso L, Castellano L, Mills A et al. Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in beta-adrenergic signaling and enhances apoptosis. Cell Death Dis 2015;6:e1754.
20. Ye L, Chang YH, Xiong Q et al. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 2014;15:750–761.
21. Nguyen PK, Neoftyou E, Rhee JW et al. Potential strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease: a review. JAMA Cardiol 2016;1:953–962.
22. Zhao T, Zhang ZN, Rong Z et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212–215.
23. Araki R, Uda M, Hoki Y et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 2013;494:100–104.
24. Guha P, Morgan JW, Mostoslavsky G et al. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 2013;12:407–412.
25. de Almeida PE, Meyer EH, Kooreman NG et al. Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance. Nat Commun 2014;5:3903.
26. Gonzalez F, Boue S, Izpisua Belmonte JC. Methods for making induced pluripotent stem cells: Reprogramming a la carte. Nat Rev Genet 2011;12:231–242.